Linkage Infrastructure, Equipment And Facilities - Grant ID: LE100100028
Funder
Australian Research Council
Funding Amount
$650,000.00
Summary
AusStage Phase 4: Harnessing collective intelligence and pioneering new visual methodologies for innovative research into Australian live performance. AusStage is the Australian internet hub for research on live performance, linking researchers in universities, industry and government. It stimulates smart information use, promotes collaboration on innovative methodologies, integrates access to collections, and provides a substrate for excellent research in the humanities. AusStage meets the nati ....AusStage Phase 4: Harnessing collective intelligence and pioneering new visual methodologies for innovative research into Australian live performance. AusStage is the Australian internet hub for research on live performance, linking researchers in universities, industry and government. It stimulates smart information use, promotes collaboration on innovative methodologies, integrates access to collections, and provides a substrate for excellent research in the humanities. AusStage meets the national need for public access to reliable information on live performance. Live performance attracts major transnational capital to Australia: its skills, innovation and creativity export Australian creativity abroad, and promote the strengths of Australian society to international audiences. The development of new performance is a key mechanism whereby Australia's national culture is generated and renewed.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE120100006
Funder
Australian Research Council
Funding Amount
$600,000.00
Summary
An adaptable and dedicated linear accelerator for medical radiation research. Leading radiation scientists developing innovative methods and devices for treating cancer patients will collaborate in future research using this highly adaptable linear accelerator for medical radiation research. Innovations in tumour targeting, better patient safety, new medical devices and improved cancer outcomes are expected.